Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

SHA:600529 Revenue

Shandong Pharmaceutical Glass Co.Ltd had revenue of 1.06B CNY in the quarter ending June 30, 2026, a decrease of -1.64%. This brings the company's total for the last twelve months to 4.50B, down -1.42% year-over-year. In the year 2025, Shandong Pharmaceutical Glass Co.Ltd had annual revenue of 4.47B, down -8.78%. That makes Shandong Pharmaceutical Glass Co.Ltd the 9,549th largest company in the world by revenue and 1,512th in China.

• Revenue (ttm): 4.50B
• Revenue Growth: -1.42%
• P/S Ratio: 2.68
• Revenue / Employee: 664.83K
• Employees: 6,775
• Market Cap: 12.08B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Packaging Products 4.22B 90.9%
• Trade 318.28M 6.8%
• Logistics Industry 94.86M 2.0%
• Service Industry 7.90M 0.2%
• Barreled Water 978.00K 0.0%

By Geography

Chart

• China 2.91B 66.0%
• Foreign 1.50B 34.0%

Fiscal year ended Dec 31, 2025 See the full SHA:600529 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.47B	-430.89M	-8.78%
Dec 31, 2024	4.90B	-77.29M	-1.55%
Dec 31, 2023	4.98B	794.92M	18.98%
Dec 31, 2022	4.19B	311.97M	8.05%
Dec 31, 2021	3.88B	448.24M	13.08%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error